Exelixis Inc: Premium Company Profile

Exelixis is a development-stage biotechnology company dedicated to the discovery and development of small molecule therapeutics for the treatment of cancer and other serious diseases. The company has a fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer.

Report Highlights
Exelixis is experienced in discovering and developing therapeutics for cancer and renal diseases. The company has in-house and collaborative pipeline products and currently has no marketed products. The company derives its revenues from contract, licensing and collaboration. During 2002-2006, the company's total revenues grew at a CAGR of 22% from $44 million in 2002 to $99 million in 2006. During the period 2006-2010, licensing, collaboration and other revenues are forecasted to grow from $99 million to $301 million. Licensing, collaboration and others would remain to be the sole revenue contributor as the company does not have any launch product or expect to launch over the period 2006-2010.
[Studien Infos ausblenden]

Overview 1
Catalyst 1
Summary 1
Company Structure 6
Company Overview and Key Facts 6
Business Description 7
History 10
Locations and Subsidiaries 15
Company Financials 16
Stock Market Performance 16
P&L 18
Balance Sheet 21
Cash Flow 21
Business Segment Performance 22
Products & Services 23
Pipeline Products 23
AC Forecast Product Sales 28
Competitors and Strategic Business Relationships 29
Key Competitors 29
Key Suppliers 29
Key Clients 29
Shareholding Structure 30
Strategy 31
Company View 31
Corporate Strategy 34
SWOT Analysis 37
Overview 37
Strengths 38
Weaknesses 40
Opportunities 41
Threats 42
Value Chain Analysis 43
Discovery and Product Development 43
Scorecard 45
Overview 45
Scorecard Analysis 46
Key Employees 47
Key Employee Biographies 48
Financial and Operational Overview 56
Financial and Operational Overview 56
APPENDIX 58
Ask the analyst 58
Datamonitor consulting 58
Disclaimer 58
[Inhaltsverzeichnis ausblenden]

Table 1: Exelixis - Key Facts 6
Table 2: Exelixis - Locations and Subsidiaries 15
Table 3: Exelixis - Year-End Share Price and Market Capitalization, 2002-2006 ($) 16
Table 4: Exelixis - Key Events Impacting Share Price Performance 17
Table 5: Exelixis - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 18
Table 6: Exelixis - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 20
Table 7: Exelixis - Balance Sheet, 2002-2006 ($ Mn) 21
Table 8: Exelixis - Cash Flow, 2002-2006 ($ Mn) 21
Table 9: Exelixis - Revenue Breakdown by Division, 2002-2006 ($ Mn) 22
Table 10: Exelixis - In-house Pipeline Products 23
Table 11: Exelixis - Collaboration Products 25
Table 12: Exelixis - Forecast Sales, 2006-2010 ($ Mn) 28
Table 13: Exelixis - Key Competitors 29
Table 14: Exelixis - Key Clients 29
Table 15: Exelixis - Key Shareholders 30
Table 16: Exelixis - SWOT Analysis Summary 37
Table 17: Exelixis - Value Chain Analysis 43
Table 18: Exelixis - Scorecard 45
Table 19: Exelixis - Key Employees 47
Table 20: Exelixis - Financial and Operational Overview 56
Figure 1: Exelixis - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 19
[Tabellenverzeichnis ausblenden]